⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Supplementary Figure S15 from Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer

Nicole A. Traphagen Gary N. Schwartz Steven Tau Alyssa M. Roberts Amanda Jiang Sarah R. Hosford Jonathan D. Marotti Abigail E. Goen Bianca A. Romo Anneka L. Johnson Emily-Claire K. Duffy Eugene Demidenko Paul Heverly Yaron Mosesson Shannon M. Soucy Fred Kolling Todd W. Miller

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Supplementary Figure S15- Individual growth curves of WHIM16 tumors from mice treated with a second cycle of E2 ± olaparib.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Traphagen et al. (2024) studied this question.

synapsesocial.com/papers/68e58589b6db64358752280d https://doi.org/10.1158/1078-0432.27033097.v1

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S15 from Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer2024
2Supplementary Figure S14 from Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer2024
3Supplementary Figure S14 from Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer2024
4Supplementary Figure S8 from Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer2024
5Supplementary Figure S8 from Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer2024

Supplementary Figure S10 from Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer2024
Supplementary Figure S10 from Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer2024
Supplementary Figure S13 from Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer2024